Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background: Hyperprolactinemia is frequent in patients with schizophrenic psychoses. It is usually regarded as an adverse effect of antipsychotics but has recently also been shown in patients without antipsychotic medication. Our objective was to test whether hyperprolactinemia occurs in antipsychotic-naive first-episode patients (FEPs). Method: In the framework of the European First Episode Schizophrenia Trial (EUFEST), 249 out of 498 FEPs were eligible for this study, of whom 74 were antipsychotic naive. All patients were investigated regarding their serum prolactin levels with immunoassays standardized against the 3rd International Reference Standard 84/500. Results: Twenty-nine (39%) of the 74 antipsychotic-naive patients showed hyperprolactinemia not explained by any other reason, 11 (50%) of 22 women and 18 (35%) of 52 men. Conclusions: Hyperprolactinemia may be present in patients with schizophrenic psychoses independent of antipsychotic medication. It might be stress induced. As enhanced prolactin can increase dopamine release through a feedback mechanism, this could contribute to explaining how stress can trigger the outbreak of psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 5×
“Dopaminergic transmission is well known to be increased in acutely psychotic patients and even in people at risk for psychosis (Howes & Kapur, 2009).”
BackgroundInfluentialKirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199903000-00006 · Cited by 1,890 · cited 1×
“In this context it is also of interest that men and women react differently to stress (Kirschbaum et al. 1999).”
BackgroundThe environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572 · cited 3×
“It is accepted that different forms of stress can enhance the risk for psychosis and may trigger its outbreak acutely (Phillips et al. 2006; van Winkel et al. 2008; Howes & Kapur, 2009; van Os et al. 2010).”
BackgroundThe Influence of Age and Sex on the Onset and Early Course of Schizophrenia
Häfner, H., Maurer, K., Löffler, W., & Riecher-Rössler, A. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.1.80 · Cited by 644
Self-citationAntipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634 · cited 2×
“In both genders it can be associated with emotional lability, loss of libido, orgasmic dysfunction and infertility (Haddad & Wieck, 2004; Miller, 2004; Prabhakar & Davis, 2008; Riecher-Rössler et al. 2009).”
Backgroundvan Winkel, R., Stefanis, N. C., & Myin-Germeys, I. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn101 · Cited by 489 · cited 3×
“It is accepted that different forms of stress can enhance the risk for psychosis and may trigger its outbreak acutely (Phillips et al. 2006; van Winkel et al. 2008; Howes & Kapur, 2009; van Os et al. 2010).”
BackgroundAntipsychotic Drugs: A New Risk Factor for Osteoporosis in Young Women With Schizophrenia?
O'Keane, V., & Meaney, A. M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150223.31007.e0 · Cited by 307
Increased stress-induced dopamine release in psychosis
Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.009 · Cited by 277
Risk of hip fracture in patients with a history of schizophrenia
Howard, L., Kirkwood, G., & Leese, M. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023671 · Cited by 158 · cited 2×
“…hyperprolactinemia has also been associated with osteopenia and osteoporosis (O‘Keane & Meaney, 2005) and an increase in the risk of bone fracture (Howard et al. 2007), although exposure to prolactin-increasing antipsychotics in one study was not found to be related to bone mineral density…”
BackgroundOsteoporosis in Patients With Schizophrenia
Hummer, M., Malik, P., Gasser, R. W., Hofer, A., Kemmler, G., Moncayo Naveda, R. C., Rettenbacher, M. A., & Fleischhacker, W. W. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.162 · Cited by 125 · cited 2×
“…has also been associated with osteopenia and osteoporosis (O‘Keane & Meaney, 2005) and an increase in the risk of bone fracture (Howard et al. 2007), although exposure to prolactin-increasing antipsychotics in one study was not found to be related to bone mineral density (Hummer et al. 2005).”
BackgroundSelf-citation
Cited by
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
Montejo, Á. L., Arango, C., Bernardo, M., Carrasco, J. L., Crespo-Facorro, B., Cruz, J. J., Del Pino-Montes, J., García-Escudero, M. A., García-Rizo, C., González-Pinto, A., et al. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.02.003 · Cited by 75
Montejo, Á. L., Arango, C., Bernardo, M., Carrasco, J. L., Crespo-Facorro, B., Cruz, J. J., del Pino, J., García Escudero, M. A., García Rizo, C., González-Pinto, A., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2015.11.003 · Cited by 55
Metadata
- Authors
- Riecher-Rössler, A., Rybakowski, J. K., Pflueger, M. O., Beyrau, R., Kahn, R. S., Malik, P., & Fleischhacker, W. W.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-04-18
- Volume
- 43
- Issue
- 12
- Pages
- 2571-2582
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2012149580
- Cited by
- 99
- References
- 14
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. https://app.cochat.ai/papers/10.1017/s0033291713000226
- The paper
- Riecher-Rössler, A., Rybakowski, J. K., Pflueger, M. O., Beyrau, R., Kahn, R. S., Malik, P., & Fleischhacker, W. W. (2013). Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. Psychological Medicine. https://doi.org/10.1017/s0033291713000226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.